Recent Episodes
Watch recent episodes on
PTV News Review
Scroll Left
Scroll Right
Speedel: Dr Alice Huxley, CEO & President




Episode Loading...




PharmaTelevision requires Javascript enabled and Adobe Flash Player to watch our programmes. If you do not have Flash installed, you can download it for free from the Adobe Flash homepage.

Improve your Internet experience and start watching exciting new video content.

Video title: Speedel: Dr Alice Huxley, CEO & President
Released on: December 01, 2006. © PharmaVentures Ltd
Visitors: You are watching a 5 minute preview.
Get more information and subscribe now
Share/save this page:
Email
Bookmark
Facebook
Twitter
LinkedIn
Follow us:
RSS
Twitter
In This Episode:
    Dr Alice Huxley talks to Fintan Walton about setting up Speedel and her motivations for doing so, following the merger of Ciba-Geigy and Sandoz in 1996 to create Novartis.
  • Summary
  • Transcript
  • Participants
  • Company
Dr Alice Huxley talks to Fintan Walton about setting up Speedel and her motivations for doing so, following the merger of Ciba-Geigy and Sandoz in 1996 to create Novartis. They discuss the company's drug development programmes and how its lead compound is nearing launch. Dr Huxley also reviews the company’s business strategy and the important balance between collaborative R&D and in-house development. Finally, she outlines the reasoning behind the decision to float Speedel on the Swiss stock exchange and discusses what the future might hold for the small biotechnology company.
Full video transcripts are available with PharmaTelevision Premium Content. Click here to buy a subscription or sign up for a 14 day free trial.
Dr Alice Huxley, CEO & President of Speedel, was previously Global Project Manager at Novartis Pharma AG. She has extensive experience in research and the drug development process in a matrix-type pharmaceutical R&D organisation. Dr Huxley has led several global multidisciplinary teams that successfully brought innovative drugs to the market.
Speedel